First opinion Flashcards
Active immunity
exposure to an antigen which stimulates the production of antigen-specific antibody (humoral) and cellular immunity.
Duration of active immunity
Takes days or weeks to develop but may result in lifelong protection
Natural active immunity
Exposure to an antigen
Acquired active immunity
Exposure to a non-virulent antigen (vaccination)
Passive immunity
Providing IgG antibodies to protect against infection
Duration of passive immunity
It gives immediate, but short-lived protection—several weeks to 3 or 4 months.
Natural passive immunity
The transfer of maternal tetanus antibody (mainly IgG) via colostrum.
Acquired passive immunity
obtaining serum from immune individuals, concentrating pooled immunoglobulin fractions and then injecting it to protect a susceptible foal or horse. Examples: tetanus antitoxin, plasma transfusion.
What is the most common type of equine vaccine?
Inactivated pathogen
Inactived pathogen vaccine
Microorganisms treated in a way which inactivates their virulence but still stimulates the immune response
Safe, easily replicated and easy to prepare
Weak humoral and cellular responses - regular boosters required and adjuvant
Protein/subunit vaccines
Extracted and purified proteins naturally produced by pathogens.
Easy to prepare, non virulent
Weak inducers of cell mediated immunity, require multiple boosters and adjuvant
Toxoid vaccines
Toxoids of bacteria
Safe, efficacious, stimulates humoral immunity
Only useful where the bacterial toxin is the agent of pethogenicity - used for tetnus and botulism in horses
Recombinant DNA vaccines
Viruses/bacteria can be genetically engineered to serve as carriers or vectors for expression of foreign DNA
Good immune response generated due to replication, safe
Difficult to engineer
Adjuvant for vaccines
Poorly understood mechanism of action; enhance antigenic presentation, improve antigenic stability, immunomodulate.
Carbomers
Aluminium salts
Immune stimulating complexes
Cytokines
Bacterial derivatives
Influenza vaccine schedule (from jan 1st 24)
First vaccine, a second 21-60 days later, and a third or booster at 120 - 180 days. Subsequent vaccines are then annual or 6-monthly for horses competing under FEI regulations.
Which two subtypes of influenza causes disease in horses?
Two subtypes of influenza A viruses: H7N7 and H3N8, of the family Orthomyxoviridae
Which is the only influenza vaccine that complies with 2010-2014 OIE?
Proteq-flu
Clinical signs of tetanus
o Erect ears, stiff tail head, muscular spasm, “rocking horse” stance
o Prolapsed nictitating membrane
o Ataxia, difficulty in walking
o Sweating, pyrexia
o Death through respiratory paralysis
What type of vaccine is the tetanus vaccine?
Purified tetanus toxoid
Vaccine protocol for tetanus
Varies between products
Primary course is 2 injections 4-6 weeks apart (from 3-6 months old)
Boosters repeated every 2-3 years
Which are the most important EHV viruses in horses?
EHV-1 and EHV-4
Clinical signs of EHV
predominantly respiratory signs, but also neurological symptoms and abortion
When is abortion caused by EHV most likely seen?
Third trimester
What kind of vaccine is used for EHV?
Inactivated - does not prevent disease but reduces severity
Which form of disease caused by EHV does the vaccine not protect against?
Neurological form
Which is the only EHV vaccine licensed in the UK?
Equip EHV 1,4 (zoetis)
Inactivated vaccine with carbomer adjuvant
Protocol of the Equip EHV 1,4 vaccine
Two initial doses 4-6 weeks apart then 6 monthly boosters. Suitable in foals from 5 months age
Use in pregnant mares to decrease abortion and reduce the risk of neonatal death is at 5,7 and 9 months gestation
Clinical signs of strangles
Highly contagious respiratory infection with widespread side effects including systemic abscessation and purpura haemorrhagica.
Respiratory signs are what give the disease its name, due to lymphadenomegaly impeding airways.
Common signs include profuse purulent nasal discharge, pyrexia and lymphadenopathy.
Vaccine for strangles
Live modified deletion mutant strain
Intramucosal vaccine into upper lip; minor local reaction (warmth, swelling, pustules) at the injection site is common. Occasional mild lymph node reactions may be seen, or in rare cases, even abscessation.
Poor efficacy, not protective in the face of an outbreak, hence not commonly used.
Two initial doses 4 weeks apart followed by boosters every 3-6 months depending on anticipated risk